Welcome
Topp puff1
Research at CMM
At CMM, KI researchers and clinical experts from KUH utilizes CMM's infrastructure and equipment which results in international top class medical research.
Puff2
Core facilities
A core is an instrument or utility that is available to all groups at CMM whereas it is housed within one group.
Donations
Donations
If you would like to support one or more of our research areas, within Sweden you can do this by using the following accounts:
News
New study shows that Proprotein Convertase 6 plays a key role in vascular disease New study shows that Proprotein Convertase 6 plays a key role in vascular disease In a new study published in Circulation Research, researchers at CMM show that the enzyme PCSK6, the...
Unexpected effect of MS drug Unexpected effect of MS drug Karl Carlström and Fredrik Piehl Photo: Stefan Zimmerman Researchers at CMM have studied the mechanism of action of a drug used to treat...
New findings about how Parkinson's disease develops New findings about how Parkinson's disease develops A new study by researchers at CMM shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs...
New method divides patients with ulcerative colitis in groups New method divides patients with ulcerative colitis in groups Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory...
Rheumatoid arthritic pain could be caused by antibodies Rheumatoid arthritic pain could be caused by antibodies In a recently published study, researchers at CMM has shown that antibodies that exist in the joints before the onset of rheumatoid...
CALENDAR
Human Systems Immunology
Speaker: Petter Brodin, M.D., Ph.D, Associate Professor, Karolinska Institutet, Department of Women's and Children's Health
CMM Lecture Hall, Visionsgatan 18, ground floor
Host: Anna Fogdell-Hahn, Anna Fogdell-Hahn, Associate Professor, Karolinska Institutet, Department of Clinical Neuroscience, Clinical Neuroimmunology, Center for Molecular Medicine, CMM
Start: 12:00
Demyelinating conditions regulated by ROS pathways outside and inside the brain.
Speaker: Karl Carlström
CMM Lecture Hall, Visionsgatan 18, ground floor, L8:00
Host:
Start: 09:00
Targeting transcriptional programmes through disruption of BET complexes
Speaker: Panagis Filippakopoulos, Associate Professor, Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford
CMM Lecture hall, Visionsgatan 18, Ground floor, L8:00
Host: Mikael Sundström,
Start: 11:30